“EXPLORATION OF HYDROXYL SUBSTITUTED REGORAFENIB DERIVATIVES AS A TYROSINE KINASE INHIBITORS OF LEUKIMIA THROUGH MOLECULAR DOCKING”, FMHR, vol. 4, no. 3, pp. 3863–3874, Mar. 2026, Accessed: Nov. 09, 2026. [Online]. Available: https://fmhr.net/index.php/fmhr/article/view/3740